Introduction

    sequence intubation in emergency departments in the United

    States.

  • Favorable characteristics include reliably good intubating
  • conditions, a rapid onset and offset of activity, non-renal

    elimination, and maintenance of the cardiorespiratory drive

  • Unfortunately, etomidate causes relative adrenal insufficiency in
  • up to 90% of patients after a single dose for up to 48 hours

  • Serious safety concerns first surfaced in the early 1980’s when
  • continuous infusions were associated with increased mortality in

    trauma patients.

    Etomidate

    Mechanism of

    Action

  • Short-acting hypnotic, which appears to have

    gamma-aminobutyric acid (GABA)-like effects.

  • Unlike the barbiturates, etomidate reduces

    subcortical inhibition at the onset of hypnosis

    while inducing neocortical sleep.

    Dose

  • 3 mg/kg IV (range 0.2 to 0.6 mg/kg)
  • Adverse

    Effects

  • Injection site pain (20%)

Clinical Detail

    Analytics. Retrieved November 6, 2018, from http://www.micromedexsolutions.com/

  • McPhee C, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis:

    analysis of a large electronic ICU database. Crit Care Med 2013; 41: 774-83.

  • den Brinker M, et al. One single dose of etomidate negatively influences adrenocortical performance for at least

    24h in children with meningococcal sepsis. Intensive Care Med. 2008 Jan;34(1):163-8.

  • Tekwani KL, et al. A comparison of the effects of etomidate and midazolam on hospital length of stay in patients

    with suspected sepsis: a prospective, randomized study. Ann Emerg Med. 2010 Nov;56(5):481-9.

  • Jabre P, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre

    randomised controlled trial. Lancet. 2009 Jul 25;374(9686):293-300

  • Cuthbertson BH, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic

    shock. Intensive Care Med. 2009 Nov;35(11):1868-76.

  • Chan CM, et al. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis.

Evidence

Evidence details are preserved from the source document in the clinical sections and references.

Conclusions

    Tekwani KL, et al. A comparison of the effects of etomidate and midazolam on hospital length of stay in patients

    with suspected sepsis: a prospective, randomized study. Ann Emerg Med. 2010 Nov;56(5):481-9.

  • Jabre P, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre

    randomised controlled trial. Lancet. 2009 Jul 25;374(9686):293-300

  • Cuthbertson BH, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic

    shock. Intensive Care Med. 2009 Nov;35(11):1868-76.

  • Chan CM, et al. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis.

References

  • Etomidate: pharmacokinetics. (2018). In Micromedex [Electronic version].Greenwood Village, CO: Truven Health

    Analytics. Retrieved November 6, 2018, from http://www.micromedexsolutions.com/

  • McPhee C, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis:

    analysis of a large electronic ICU database. Crit Care Med 2013; 41: 774-83.

  • den Brinker M, et al. One single dose of etomidate negatively influences adrenocortical performance for at least

    24h in children with meningococcal sepsis. Intensive Care Med. 2008 Jan;34(1):163-8.

  • Tekwani KL, et al. A comparison of the effects of etomidate and midazolam on hospital length of stay in patients

    with suspected sepsis: a prospective, randomized study. Ann Emerg Med. 2010 Nov;56(5):481-9.

  • Jabre P, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre

    randomised controlled trial. Lancet. 2009 Jul 25;374(9686):293-300

  • Cuthbertson BH, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic

    shock. Intensive Care Med. 2009 Nov;35(11):1868-76.

  • Chan CM, et al. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis.

Tags:etomidate RSI septic shock adrenal suppression